Oncology alternative payment models: lessons from commercial insurance

Area of Science:

• Healthcare economics
• Health policy
• Oncology practice management

Background:

• Value-based care (VBC) initiatives are increasingly adopted by payers and clinicians.
• Alternative payment models (APMs) are key VBC strategies designed to enhance care quality and reduce costs.
• Specialty fields, particularly oncology, face unique obstacles in APM implementation.

Purpose of the Study:

• To examine the practical challenges and scalability issues encountered in implementing APM pilots in oncology.
• To assess the perspectives of payers and clinicians on the viability and effectiveness of APMs in specialty care.
• To provide insights into the realistic considerations for designing and transferring risk in APM frameworks.

Main Methods:

• Analysis of observations from a multistakeholder working group focused on APM implementation.
• Review of reported experiences from APM pilots involving commercial and Medicare Advantage populations in oncology.
• Qualitative assessment of payer feedback regarding emerging best practices and optimism for APMs.

Main Results:

• Significant practical challenges and limited episode/patient numbers hinder APM viability and scalability in oncology.
• Despite challenges, some payers report positive emerging practices and maintain optimism about APMs.
• The feasibility of risk transfer in APM design requires careful and realistic examination.

Conclusions:

• Implementing APMs in specialized fields like oncology presents considerable headwinds to widespread adoption and success.
• Realistic goal-setting and thorough evaluation of risk-transfer mechanisms are crucial for effective APM design and implementation.
• Continued payer and clinician commitment, coupled with adaptive strategies, may foster the advancement of value-based care through APMs.